'We're in': Roche and Genentech join forces on a multibillion-dollar discovery pact with a brash AI upstart
Over the past couple of years, the top execs at Roche and Genentech have inked a flurry of deals aligning the global pair with several of the new players that have emerged in the booming AI and machine learning world. That strategy was supercharged in the spring of 2020 by their decision to recruit Aviv Regev out of the computational world she occupied at the Broad. And today they’re taking that computational approach in R&D to a whole new level.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.